VW van Hinsbergh

2.2k total citations
22 papers, 1.8k citations indexed

About

VW van Hinsbergh is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, VW van Hinsbergh has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 13 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in VW van Hinsbergh's work include Blood Coagulation and Thrombosis Mechanisms (13 papers), Protease and Inhibitor Mechanisms (13 papers) and Blood properties and coagulation (6 papers). VW van Hinsbergh is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (13 papers), Protease and Inhibitor Mechanisms (13 papers) and Blood properties and coagulation (6 papers). VW van Hinsbergh collaborates with scholars based in Netherlands and United Kingdom. VW van Hinsbergh's co-authors include T. Kooistra, J.J. Emeis, Walter Fiers, L Monnens, Mohamed A. Karmali, R M Bertina, A van Wijngaarden, F. Haverkate, J. Hajo van Bockel and M. Apecechea de Scheffer and has published in prestigious journals such as Blood and Fibrinolysis and Proteolysis.

In The Last Decade

VW van Hinsbergh

22 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
VW van Hinsbergh Netherlands 14 707 437 436 373 325 22 1.8k
Roberto Conte Italy 25 704 1.0× 504 1.2× 109 0.3× 69 0.2× 684 2.1× 81 2.1k
D. Maroeska W. M. te Loo Netherlands 22 209 0.3× 310 0.7× 93 0.2× 336 0.9× 297 0.9× 73 1.5k
Ann‐Charlotte Kristoffersson Sweden 21 451 0.6× 735 1.7× 62 0.1× 145 0.4× 252 0.8× 45 1.2k
Gerard R. Majeau United States 18 668 0.9× 1.4k 3.3× 224 0.5× 13 0.0× 510 1.6× 18 2.8k
A. J. M. Eerenberg Netherlands 19 442 0.6× 773 1.8× 97 0.2× 14 0.0× 280 0.9× 21 1.8k
Mitchell D. Botney United States 21 74 0.1× 136 0.3× 234 0.5× 62 0.2× 387 1.2× 34 1.8k
Cristina Lupu United States 22 593 0.8× 433 1.0× 141 0.3× 10 0.0× 340 1.0× 49 1.5k
Estelle S. Harris United States 18 358 0.5× 1000 2.3× 124 0.3× 13 0.0× 366 1.1× 23 1.8k
Gary Sinclair Canada 13 740 1.0× 1.4k 3.1× 73 0.2× 14 0.0× 578 1.8× 25 2.3k
Aime T. Franco United States 18 118 0.2× 565 1.3× 299 0.7× 34 0.1× 773 2.4× 44 2.2k

Countries citing papers authored by VW van Hinsbergh

Since Specialization
Citations

This map shows the geographic impact of VW van Hinsbergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by VW van Hinsbergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites VW van Hinsbergh more than expected).

Fields of papers citing papers by VW van Hinsbergh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by VW van Hinsbergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by VW van Hinsbergh. The network helps show where VW van Hinsbergh may publish in the future.

Co-authorship network of co-authors of VW van Hinsbergh

This figure shows the co-authorship network connecting the top 25 collaborators of VW van Hinsbergh. A scholar is included among the top collaborators of VW van Hinsbergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with VW van Hinsbergh. VW van Hinsbergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Hanemaaijer, Roeland, et al.. (1994). Plasminogen activator regulation studies following transfection of human endothelial cells. Fibrinolysis and Proteolysis. 8. 19–21. 1 indexed citations
5.
6.
7.
Hinsbergh, VW van, et al.. (1990). Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood. 75(10). 1991–1998. 1 indexed citations
8.
9.
10.
Hinsbergh, VW van, et al.. (1990). Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood. 75(7). 1490–1497. 200 indexed citations
11.
Hinsbergh, VW van, et al.. (1990). Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood. 75(7). 1490–1497. 2 indexed citations
12.
Hinsbergh, VW van, et al.. (1990). Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood. 75(10). 1991–1998. 148 indexed citations
13.
14.
15.
Kluft, Cornelis, et al.. (1986). The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood. Blood. 67(3). 616–622. 29 indexed citations
16.
Haverkate, F., et al.. (1986). The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood. 67(4). 1189–1192. 74 indexed citations
17.
Kluft, Cornelis, P. Łoś, A.F.H. Jie, et al.. (1986). The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood. Blood. 67(3). 616–622. 37 indexed citations
18.
Bertina, R M, et al.. (1986). The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro. Blood. 67(4). 1189–1192. 1 indexed citations
19.
Hinsbergh, VW van, et al.. (1985). Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood. 65(2). 444–451. 256 indexed citations
20.
Hinsbergh, VW van, et al.. (1985). Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood. 65(2). 444–451. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Conte Breakdown of academic impact, for papers by D. Maroeska W. M. te Loo Breakdown of academic impact, for papers by Ann‐Charlotte Kristoffersson Breakdown of academic impact, for papers by Gerard R. Majeau Breakdown of academic impact, for papers by A. J. M. Eerenberg Breakdown of academic impact, for papers by Mitchell D. Botney Breakdown of academic impact, for papers by Cristina Lupu Breakdown of academic impact, for papers by Estelle S. Harris Breakdown of academic impact, for papers by Gary Sinclair Breakdown of academic impact, for papers by Aime T. Franco
Rankless by CCL
2026